PD-1/PD-L1 Are Novel Therapeutic Targets for Mastocytosis

被引：0
|
作者：
Geeze, Mary
Hatch, Ellen
Martin, Cheyenne
Perkins, Sherrie L.
Hartmann, Karin
Valent, Peter
Gotlib, Jason
Lidke, Diane
George, Tracy I.
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Med Univ Lubeck, D-23538 Lubeck, Germany
[4] Med Univ Vienna, Vienna, Austria
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1371
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [21] PD-1 and PD-L1 antibodies for melanoma
    Tsai, Katy K.
    Zarzoso, Ines
    Daud, Adil I.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3111 - 3116
  • [22] Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
    Wang, Zhijie
    Yuan, Lin
    Liao, Xiaotong
    Guo, Xia
    Chen, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6027 - 6043
  • [23] PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
    Yaghoubi, Neda
    Soltani, Arash
    Ghazvini, Kiarash
    Hassanian, Seyed Mahdi
    Hashemy, Seyed Isaac
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 312 - 318
  • [24] Novel, small molecule inhibitors of PD-1/PD-L1 pathway
    Rastelli, Luca
    Rajagopal, Sridharan
    Gajendran, Chandru
    Sadhu, Naveen M.
    Mohd, Zainuddin
    Gosu, Ramachandraiah
    Friedmann-Morvinski, Dinorah
    Kandan, Saravanan
    Birudukota, Swarnakumari
    Srinivasan, S.
    Krishnakumar, V
    Wahid, Saif
    Siddiqui, Amir
    Viswakarma, Santosh
    Narayan, Ashwini
    Rudresh, G.
    Mullurwar, Sadanand R.
    Sher, Divsha
    Mansur, Shahar
    Sivanandhan, Dhanalakshmi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [26] PD-L1/PD-1 axis as a potent therapeutic target in breast cancer
    Bastaki, Shima
    Irandoust, Mahzad
    Ahmadi, Armin
    Hojjat-Farsangi, Mohammad
    Ambrose, Patrick
    Hallaj, Shahin
    Edalati, Mahdi
    Ghalamfarsa, Ghasem
    Azizi, Gholamreza
    Yousefi, Mehdi
    Chalajour, Hengameh
    Jadidi-Niaragh, Farhad
    LIFE SCIENCES, 2020, 247
  • [27] The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema
    Kim, Jiseon
    Kim, Na Hyun
    Shon, Chang-Ho
    Huh, Jin-Young
    Han, Kyung Yeon
    Kim, Kyu-Tae
    Shin, Sun Hye
    Park, Hye Yun
    Lee, Sei Won
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [28] Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1
    Jiang, Mengzhen
    Liu, Man
    Liu, Guodi
    Ma, Jiawen
    Zhang, Lixin
    Wang, Shenlin
    MABS, 2023, 15 (01)
  • [29] In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
    Chih-Hao Lu
    Wei-Min Chung
    Chun-Hao Tsai
    Ju-Chien Cheng
    Kai-Cheng Hsu
    Huey-En Tzeng
    Scientific Reports, 12
  • [30] In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
    Lu, Chih-Hao
    Chung, Wei-Min
    Tsai, Chun-Hao
    Cheng, Ju-Chien
    Hsu, Kai-Cheng
    Tzeng, Huey-En
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345